Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease.
慢性腎臟病患者靜脈注射鐵劑對纖維母細胞生長因子23和磷酸鹽影響之比較性探索性雙盲隨機研究的方法論和基線數據。
Kidney Blood Press Res 2024-04-12
Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease.
血清鐵指標、鐵補充與慢性腎臟病未進行透析患者心血管疾病發病率之關聯。
Nephrol Dial Transplant 2023-12-17
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
住院心衰及腎功能降低的鐵缺乏患者中的羥基甲基澱粉鐵。
Clin J Am Soc Nephrol 2023-10-12
Bone marrow macrophage iron content and sideroblast count in iron- and ESA-naïve patients with CKD-related anemia.
慢性腎臟病相關貧血患者中未接受鐵製劑和ESA治療的骨髓巨噬細胞鐵含量和鐵粒幹細胞計數。
Ren Fail 2023-07-18
Comparative Efficacy and Acceptability of 12 Phosphorus-Lowering Drugs in Adults with Hyperphosphatemia and Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.
慢性腎臟病高磷血症成人使用12種降磷藥物的比較療效和可接受性:系統性回顧和網絡荟萃分析。
Blood Purif 2023-09-13
Efficacy and Safety of Ferric Citrate on Hyperphosphatemia among Chinese Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Phase III Multicenter Randomized Open-Label Active-Drug-Controlled Study.
鐵檸檬酸鐵對中國慢性腎臟病血液透析患者高磷血症的療效和安全性:第三期多中心隨機開放標籤活性藥物對照研究。
Am J Nephrol 2023-12-16
The association between transferrin saturation and all-cause mortality in chronic kidney disease: findings from Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease.
慢性腎臟病中轉鐵蛋白飽和度與全因死亡率之關聯:來自韓國慢性腎臟病患者結果的研究。
Kidney Res Clin Pract 2024-06-27
A Randomized Trial of the IMPACT of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
接受透析治療患者中鐵檸檬酸鐵對促紅細胞生成素和靜脈注射鐵使用影響的隨機試驗。
Am J Nephrol 2024-07-07